The role of gp39 (CD40L) in immunity
Open Access
- 30 September 1995
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 76 (3) , S203-S207
- https://doi.org/10.1016/s0090-1229(95)90234-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mice deficient for the CD40 ligandPublished by Elsevier ,1994
- The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formationPublished by Elsevier ,1994
- The CD40 Antigen and its LigandAnnual Review of Immunology, 1994
- In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.The Journal of Experimental Medicine, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Identification of a source of biologically active CD40 ligandEuropean Journal of Immunology, 1992
- Membranes of activated CD4+ T cells expressing T cell receptor (TcR) αβ or TcR γδ induce IgE synthesis by human B cells in the presence of interleukin‐4European Journal of Immunology, 1992
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens.The Journal of Experimental Medicine, 1992
- Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptorNature, 1989